FORT LEE, N.J., March 20 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global specialty pharmaceutical company, will be hosting an Investor Meeting on Tuesday, March 21, 2006 at 8:00am at The Four Seasons Hotel in New York City. This presentation will be webcast in a listen only mode and can be accessed via the Internet at http://www.streetevents.com or http://www.companyboardroom.com. A rebroadcast will be available on these websites from Tuesday, March 21, 2006 until midnight Friday, March 24, 2006.
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Alpharma Inc.CONTACT: Kathleen Makrakis -- VP, Investor Relations for Alpharma Inc.,kathleen.makrakis@alpharma.com, or +1-201-228-5085
